Successful management plan of COVID-19 in a pediatric hemato-oncology department: a single-centre experience.
Pio StellatoAnnalisa GranataAntonia De MatteoCarlo CapelliMatteo PaparoRosanna ParasoleImmacolata RicciardiFrancesco Paolo TambaroOrnella LeoneLucia QuagliettaGiuseppe MennaNicola SilvestriPublished in: BMJ paediatrics open (2020)
COVID-19 pandemic raised concern about management of patients with paediatric cancer. We present the operating system that the Hemato-Oncology Department of the Santobono-Pausilipon Hospital applied. We divided our department in three zones: surveillance and screening; quarantine and COVID free, in order to screen admitted patients and to reduce the risk of cross infection. From 3 April until 29 May 2020 (56 days), 662 patients and caregivers underwent rapid serological tests for a total of 1397 assays. No patient or parent with SARS-CoV2 infection was found, demonstrating the effectiveness of COVID-19 screening process.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- newly diagnosed
- ejection fraction
- palliative care
- chronic kidney disease
- randomized controlled trial
- public health
- emergency department
- systematic review
- healthcare
- squamous cell carcinoma
- intensive care unit
- respiratory syndrome coronavirus
- high throughput
- patient reported outcomes
- case report
- lymph node metastasis
- loop mediated isothermal amplification
- sensitive detection